mavorixafor will boost the stage or impact of codeine by impacting hepatic enzyme CYP2D6 metabolism. Contraindicated. Mavorixafor (a robust CYP2D6 inhibitor) is contraindicated with medicine which have been very dependent on CYP2D6 for clearance.Polityka prywatno?ci cookie W momencie odwiedzenia przez U?ytkownika Portalu, gromadzone s? pliki cookie